Wave Life Sciences Ltd. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stoc kholder Matters and Issuer Purchases of Equity Securities Market Information Our ordinary shares are traded on the Nasdaq Global Market under the symbol “WVE”. Shareholders As of February 19, 2026, we had 188,254,954 ordinary shares outstanding and approximately seven shareholders of record of our ordinary shares. Share Performance Graph The following share performance graph compares our total share return with the total return for (i) the Nasdaq Composite Index and (ii) the Nasdaq Biotechnology Index for the period from December 31, 2020 through December 31, 2025. The figures represented below assume an investment of $100.00 in our ordinary shares at the closing price of $7.870 on December 31, 2020 and in the Nasdaq Composite Index and the Nasdaq Biotechnology Index on December 31, 2020 and the reinvestment of dividends, if any, into ordinary shares. The share return shown in the share performance graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future share return. This performance graph is not “soliciting material,” is not deemed filed with the SEC and is not to be incorporated by reference in any filing by us under the Securities Act or the Exchange Act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. Dividends We have never declared or paid cash dividends on our ordinary shares. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business, and we do not anticipate paying any cash dividends on our ordinary shares in the foreseeable future. In addition, the terms of any future debt agreements may preclude us from paying dividends. Unregistered Sales of Securities Not applicable. Issuer Purchases of Equity Securities None. Item 6. [ Reserved]